Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. | Neuropathology | 2022 | 35859319 | PubTator, text mining | PubMed |
| ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome. | Genome Res | 2022 | 35858748 | PubTator, text mining | PubMed |
| Latest developments in the pathobiology of Ewing sarcoma. | J Bone Oncol | 2022 | 35855933 | PubTator, text mining | PubMed |
| Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma. | Acta Neuropathol Commun | 2022 | 35836290 | PubTator, text mining | PubMed |
| FGF8-FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner. | Dis Model Mech | 2022 | 35833364 | PubTator, text mining | PubMed |
| Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence In Situ Hybridization Detection for NCOA2 Rearrangement. | Front Oncol | 2022 | 35832542 | PubTator, text mining | PubMed |
| Hepatitis C Virus Core Protein Promotes the Metastasis of Human Hepatocytes by Activating the MAPK/ERK/PEA3-SRF/c-Fos/MMPs Axis. | Arch Med Res | 2022 | 35817647 | PubTator, text mining | PubMed |
| ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2. | Int J Med Sci | 2022 | 35813298 | PubTator, text mining | PubMed |
| Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis. | Kidney Int Rep | 2022 | 35812284 | PubTator, text mining | PubMed |
| Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. | Cancers (Basel) | 2022 | 35805035 | PubTator, text mining | PubMed |
| The Cupid shuffle: Do enhancers prefer specific promoters? | Mol Cell | 2022 | 35803216 | PubTator, text mining | PubMed |
| A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview. | J Ovarian Res | 2022 | 35799305 | PubTator, text mining | PubMed |
| Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1. | Open Med (Wars) | 2022 | 35795002 | PubTator, text mining | PubMed |
| Neferine Exerts Ferroptosis-Inducing Effect and Antitumor Effect on Thyroid Cancer through Nrf2/HO-1/NQO1 Inhibition. | J Oncol | 2022 | 35794985 | PubTator, text mining | PubMed |
| CD44 In Sarcomas: A Comprehensive Review and Future Perspectives. | Front Oncol | 2022 | 35785191 | PubTator, text mining | PubMed |
| Core cysteine residues in the Plasminogen-Apple-Nematode (PAN) domain are critical for HGF/c-MET signaling. | Commun Biol | 2022 | 35778602 | PubTator, text mining | PubMed |
| Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. | Gastroenterology | 2022 | 35777482 | PubTator, text mining | PubMed |
| MicroRNA-4516 suppresses proliferative vitreoretinopathy development via negatively regulating OTX1. | PLoS One | 2022 | 35771766 | PubTator, text mining | PubMed |
| Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment. | Front Genet | 2022 | 35754804 | PubTator, text mining | PubMed |
| Distinct interactors define the p63 transcriptional signature in epithelial development or cancer. | Biochem J | 2022 | 35748701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=27